Skip to main content

Advertisement

Log in

Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine

  • Original article
  • Published:
Blut Aims and scope Submit manuscript

Summary

Severe aplastic anemia developed in a patient after administration of quinacrine for treatment of discoid lupus erythematosus. Marrow transplantation was performed from an HLA genotypically identical sister after conditioning with cyclophosphamide. Quinacrine which was accumulated in the patient tissues did not interfere with engraftment, suggesting that the drug has no direct cytotoxic effect on hematopoietic stem cells. This study extends our previous observation that severe aplastic anemia acquired after exposure to drugs or toxins can be cured by marrow transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anasetti C, Doney K, Storb R, Meyers JD, Farewell VT, Buckner CD, Appelbaum FR, Sullivan KM, Clift RA, Deeg HJ, Fefer A, Martin PJ, Singer JW, Sanders JE, Stewart PS, Witherspoon RP, Thomas ED (1986) Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty “untransfused” patients. Ann Int Med 104: 461–466

    Google Scholar 

  2. Biro L, Leone N (1965) Aplastic anemia induced by quinacrine. Arch Dermatol 92: 574–576

    Google Scholar 

  3. Bithell TC, Wintrobe MM (1967) Drug-induced aplastic anemia. Semin Hematol 4: 194

    Google Scholar 

  4. Böttiger LE, Westerholm B (1972) Aplastic anemia. II. Druginduced aplastic anemia. Acta Med Scand 192: 319

    Google Scholar 

  5. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R (1976) Severe aplastic anemia: A prospective study of the effect of early marrow transplantation on acute mortality. Blood 48: 63–70

    Google Scholar 

  6. Custer RP (1946) Aplastic anemia in soldiers treated with atabrine (quinacrine). Am J Med Soc 212: 211–224

    Google Scholar 

  7. Dutrillaux B, Lejeune J (1975) New techniques in the study of human chromosomes: methods and application. Adv Hum Genet 5: 119

    Google Scholar 

  8. Findley GM (1951) Recent advances in chemotherapy, Vol II. Churchill, London, pp 222–223

    Google Scholar 

  9. Fishman A, Kinsman JM (1949) Hypoplastic anemia due to atabrine. Blood 4: 970

    Google Scholar 

  10. Freedman A (1956) Mepacrine versus chloroquine. Ann Rheum Dis 15: 251

    Google Scholar 

  11. Freedman A, Bach F (1952) Mepacrine and rheumatoid arthritis. Lancet 263: 321

    Google Scholar 

  12. Gebster LT (1985) Drugs used in the chemotherapy of protozoal infections (amebiasis, giardiasis and trichomoniasis). In: Goodman, Gilman A, Goodman LS, Rall ThW, Murad F (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 1049–1057

    Google Scholar 

  13. Heimpel H, Heit W (1980) Drug-induced aplastic anemia: clinical aspects. Clin Haematol 9: 641–62

    Google Scholar 

  14. Mainland D, Sutcliffe MI (1962) Hydroxy-chloroquine sulfate in rheumatoid arthritis, a six months double-blind trial. Bull Rheum Dis 13: 287

    Google Scholar 

  15. Namiuchi S, Kumagai S, Imura H, Suginoshila T, Hallori T, Hirata F (1984) Quinacrine inhibits the primary but not secondary proliferative response of human cytotoxic T cells to allogeneic non-T-cell antigens. J Immunol 132: 1456–61

    Google Scholar 

  16. Pachman U, Rigler R (1972) Quantum yield of acridines interacting with DNA of defined base sequence. Exp Cell Res 72: 602

    Google Scholar 

  17. Page F (1951) Treatment of lupus erythematosus with mepacrine. Lancet 261: 755–58

    Google Scholar 

  18. Parmer LG (1984) Blood and bone marrow concentration of atabrine and its role in aplastic anemia. J Lab Clin Med 33: 827–832

    Google Scholar 

  19. Parmer LG, Sawitsky A (1953) Fatal aplastic anemia following quinacrine therapy in chronic discoid lupus erythematosus. JAMA 13: 272–74

    Google Scholar 

  20. Paton MD, Ridell MJ, Strong JA (1955) Aplastic anemia following mepacrine treatment of lupus erythematosus. Lancet I: 281

    Google Scholar 

  21. Powell RD (1966) The chemotherapy of malaria. Clin Pharmacol Ther 7: 48

    Google Scholar 

  22. Schur PH (1971) Systemic lupus erythematosus. In: Beeson PS, McCermott W, Wyngaarden JB (eds) Textbook of medicine. Saunders, Philadelphia

    Google Scholar 

  23. Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice PL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP (1984) Marrow transplantation for aplastic anemia. Semin Hematol 21: 27–35

    Google Scholar 

  24. Vencent PC (1986) Drug-induced anemia and agranulocytosis. Incidence and mechanisms. Drugs 31: 52–63

    Google Scholar 

  25. Wilkinson DS (1954) Vascular basis of some nodular cruptions of legs. Br J Dermatol 66: 201–213

    Google Scholar 

  26. Wolfe MS, Wintrobe MM (1975) Giardiasis. JAMA 233: 1362–1365

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmid, I., Anasetti, C., Petersen, F.B. et al. Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine. Blut 61, 52–54 (1990). https://doi.org/10.1007/BF02076699

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02076699

Key words

Navigation